E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma
Authors
Keywords
-
Journal
Medicina-Lithuania
Volume 51, Issue 1, Pages 1-9
Publisher
MDPI AG
Online
2015-01-30
DOI
10.1016/j.medici.2015.01.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma
- (2014) Chun-Lin Wang et al. CARCINOGENESIS
- Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
- (2014) S. Nag et al. CURRENT MEDICINAL CHEMISTRY
- Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase
- (2014) C Xu et al. ONCOGENE
- Ubiquitin-proteasome system, a new anti-tumor target
- (2013) Wei Du et al. ACTA PHARMACOLOGICA SINICA
- Non-degradative ubiquitination of the Notch1 receptor by the E3 ligase MDM2 activates the Notch signalling pathway
- (2013) Susanne Pettersson et al. BIOCHEMICAL JOURNAL
- Following Ariadne's thread: a new perspective on RBR ubiquitin ligases
- (2013) Dawn M Wenzel et al. BMC BIOLOGY
- Macromolecular juggling by ubiquitylation enzymes
- (2013) Sonja Lorenz et al. BMC BIOLOGY
- Clinical characteristics and outcomes with specificBRAFandNRASmutations in patients with metastatic melanoma
- (2013) Amanda D. Bucheit et al. CANCER
- Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases
- (2013) Weihua Zhou et al. CELL RESEARCH
- Cullin-RING Ligases as Attractive Anti-cancer Targets
- (2013) Yongchao Zhao et al. CURRENT PHARMACEUTICAL DESIGN
- Fbw7 dimerization determines the specificity and robustness of substrate degradation
- (2013) M. Welcker et al. GENES & DEVELOPMENT
- Ubiquitinations in the Notch Signaling Pathway
- (2013) Julien Moretti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of SKP1-CUL1-F-Box-Protein (SCF) E3 Ubiquitin Ligases in Skin Cancer
- (2013) Chuan-Ming Xie et al. Journal of Genetics and Genomics
- Prognostic Significance of Fbw7 in Human Melanoma and Its Role in Cell Migration
- (2013) Yabin Cheng et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Signal Transduction Pathway from TGF-β1 to SKP2 via Akt1 and c-Myc and its Correlation with Progression in Human Melanoma
- (2013) Xuan Qu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Ubiquitin Code
- (2012) David Komander et al. Annual Review of Biochemistry
- Specific Small Molecule Inhibitors of Skp2-Mediated p27 Degradation
- (2012) Lily Wu et al. CHEMISTRY & BIOLOGY
- Tumor suppressor functions of FBW7 in cancer development and progression
- (2012) Zhiwei Wang et al. FEBS LETTERS
- MDM2 Protein-mediated Ubiquitination of NUMB Protein
- (2012) Matylda Sczaniecka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HECT and RING finger families of E3 ubiquitin ligases at a glance
- (2012) M. B. Metzger et al. JOURNAL OF CELL SCIENCE
- Fbw7 and Fbw7 Collaborate To Shuttle Cyclin E1 into the Nucleolus for Multiubiquitylation
- (2012) N. Bhaskaran et al. MOLECULAR AND CELLULAR BIOLOGY
- Triggering Fbw7-Mediated Proteasomal Degradation of c-Myc by Oridonin Induces Cell Growth Inhibition and Apoptosis
- (2012) H.-L. Huang et al. MOLECULAR CANCER THERAPEUTICS
- Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma
- (2012) Luca Busino et al. NATURE CELL BIOLOGY
- MDM4 is a key therapeutic target in cutaneous melanoma
- (2012) Agnieszka Gembarska et al. NATURE MEDICINE
- Opposing functions of Fbxw7 in keratinocyte growth, differentiation and skin tumorigenesis mediated through negative regulation of c-Myc and Notch
- (2012) Y Ishikawa et al. ONCOGENE
- Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells
- (2012) M Wade et al. ONCOGENE
- Novel Multiple Markers to Distinguish Melanoma from Dysplastic Nevi
- (2012) Guohong Zhang et al. PLoS One
- Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase
- (2012) Yi Sun et al. Protein & Cell
- Chemical genetics approach to restoring p27Kip1 reveals novel compounds with antiproliferative activity in prostate cancer cells
- (2011) Elizabeth Rico-Bautista et al. BMC BIOLOGY
- Role of the ubiquitin ligase Fbw7 in cancer progression
- (2011) Yabin Cheng et al. CANCER AND METASTASIS REVIEWS
- Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3a
- (2011) R. C. Brennan et al. CANCER RESEARCH
- MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression
- (2011) Mikael Lerner et al. CELL CYCLE
- SCF E3 Ubiquitin Ligases as Anticancer Targets
- (2011) L. Jia et al. CURRENT CANCER DRUG TARGETS
- SAG/RBX2/ROC2 E3 Ubiquitin Ligase Is Essential for Vascular and Neural Development by Targeting NF1 for Degradation
- (2011) Mingjia Tan et al. DEVELOPMENTAL CELL
- Trp53 regulates Notch 4 signaling through Mdm2
- (2011) Y. Sun et al. JOURNAL OF CELL SCIENCE
- p53 Rescue through HDM2 Antagonism Suppresses Melanoma Growth and Potentiates MEK Inhibition
- (2011) Zhenyu Ji et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Deubiquitinases in cancer: new functions and therapeutic options
- (2011) J M Fraile et al. ONCOGENE
- Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas
- (2011) Gisele Nai et al. PATHOLOGY RESEARCH AND PRACTICE
- Cytoplasmic Skp2 Expression Is Increased in Human Melanoma and Correlated with Patient Survival
- (2011) Guangdi Chen et al. PLoS One
- Silymarin Targets β-Catenin Signaling in Blocking Migration/Invasion of Human Melanoma Cells
- (2011) Mudit Vaid et al. PLoS One
- The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
- (2011) L. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of Mdm2-MdmX E3 Ligase Inhibitors Using a Cell-Based Ubiquitination Assay
- (2011) A. G. Herman et al. Cancer Discovery
- The cullin protein family
- (2011) Antonio Sarikas et al. GENOME BIOLOGY
- A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53
- (2010) Federico Bernal et al. CANCER CELL
- Validation of SAG/RBX2/ROC2 E3 Ubiquitin Ligase as an Anticancer and Radiosensitizing Target
- (2010) L. Jia et al. CLINICAL CANCER RESEARCH
- Ubiquitylation of an ERAD Substrate Occurs on Multiple Types of Amino Acids
- (2010) Yuichiro Shimizu et al. MOLECULAR CELL
- Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis
- (2010) J Li et al. ONCOGENE
- Growth and progression of melanoma and non-melanoma skin cancers regulated by ubiquitination
- (2010) Koh Nakayama Pigment Cell & Melanoma Research
- Clinical relevance of SKP2 alterations in metastatic melanoma
- (2010) Amy E. Rose et al. Pigment Cell & Melanoma Research
- Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism
- (2009) P. Secchiero et al. BLOOD
- Diversification of the cullin family
- (2009) Ignacio Marín BMC EVOLUTIONARY BIOLOGY
- p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function
- (2009) Shicheng Liu et al. CANCER LETTERS
- Quantitative Proteomics Reveals the Function of Unconventional Ubiquitin Chains in Proteasomal Degradation
- (2009) Ping Xu et al. CELL
- Restriction of Src Activity by Cullin-5
- (2009) George S. Laszlo et al. CURRENT BIOLOGY
- CRL4s: the CUL4-RING E3 ubiquitin ligases
- (2009) Sarah Jackson et al. TRENDS IN BIOCHEMICAL SCIENCES
- Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer
- (2008) Dan D. Hershko CANCER
- The Fbxw7/hCdc4 tumor suppressor in human cancer
- (2008) YingMeei Tan et al. CANCER LETTERS
- NUMB controls p53 tumour suppressor activity
- (2008) Ivan N. Colaluca et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started